Description
Atrial Fibrillation Devices Market was valued at 7.4 billion in 2021, and it is estimated to reach USD 15.2 billion by 2028, with a CAGR of 14% during the forecast of 2022-2028. Growth in the prevalence of obesity and hypertension among the senior population reduced mortality rate, and favorable consequences of the atrial fibrillation device are predicted to drive the global atrial fibrillation device market growth. Moreover, the atrial fibrillation device is an option for long-term oral anticoagulants among non-valvular atrial fibrillation (NVAF) patients, eliminates long-term warfarin, and reduces the chance of heart bleeding and strokes fuel the change of the global atrial fibrillation device market.
